4-(4-chlorophenyl)-2-(piperidin-4-yl)thiazole | 927020-17-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-(4-chlorophenyl)-2-(piperidin-4-yl)thiazole
• 英文别名: 4-[4-(4-Chlorophenyl)-1,3-thiazol-2-yl]piperidine；4-(4-chlorophenyl)-2-piperidin-4-yl-1,3-thiazole
• CAS: 927020-17-5
• 化学式: C₁₄H₁₅ClN₂S
• mdl: MFCD09891566
• 分子量: 278.805
• InChiKey: CMAURUWXPKFGBL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.357
• 拓扑面积：
  53.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(4-chlorophenyl)-2-(piperidin-4-yl)thiazole 、 乙酰氯 在 三乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 3.25h， 以57.9%的产率得到1-(4-(4-(4-chlorophenyl)thiazol-2-yl)piperidin-1-yl)ethanone
  参考文献：
  名称：

  Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System

  摘要：

  Diarylthiazole (DAT), a hit from diversity screening, was found to have potent antimycobacterial activity against Mycobacterium tuberculosis (Mtb). In a systematic medicinal chemistry exploration, we demonstrated chemical opportunities to optimize the potency and physicochemical properties. The effort led to more than 10 compounds with submicromolar MICs and desirable physicochemical properties. The potent antimycobacterial activity, in conjunction with low molecular weight, made the series an attractive lead (antibacterial ligand efficiency (ALE)>0.4). The series exhibited excellent bactericidal activity and was active against drug-sensitive and resistant Mtb. Mutational analysis showed that mutations in prrB impart resistance to DAT compounds but not to reference drugs tested. The sensor kinase PrrB belongs to the PrrBA two component system and is potentially the target for DAT. PrrBA is a conserved, essential regulatory mechanism in Mtb and has been shown to have a role in virulence and metabolic adaptation to stress. Hence, DATs provide an opportunity to understand a completely new target system for antimycobacterial drug discovery.

  DOI：

  10.1021/jm500833f
• 作为产物：
  描述：

  哌啶-4-甲酰胺 在 劳森试剂 、 三氟乙酸 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 11.0h， 生成 4-(4-chlorophenyl)-2-(piperidin-4-yl)thiazole
  参考文献：
  名称：

  Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System

  摘要：

  Diarylthiazole (DAT), a hit from diversity screening, was found to have potent antimycobacterial activity against Mycobacterium tuberculosis (Mtb). In a systematic medicinal chemistry exploration, we demonstrated chemical opportunities to optimize the potency and physicochemical properties. The effort led to more than 10 compounds with submicromolar MICs and desirable physicochemical properties. The potent antimycobacterial activity, in conjunction with low molecular weight, made the series an attractive lead (antibacterial ligand efficiency (ALE)>0.4). The series exhibited excellent bactericidal activity and was active against drug-sensitive and resistant Mtb. Mutational analysis showed that mutations in prrB impart resistance to DAT compounds but not to reference drugs tested. The sensor kinase PrrB belongs to the PrrBA two component system and is potentially the target for DAT. PrrBA is a conserved, essential regulatory mechanism in Mtb and has been shown to have a role in virulence and metabolic adaptation to stress. Hence, DATs provide an opportunity to understand a completely new target system for antimycobacterial drug discovery.

  DOI：

  10.1021/jm500833f

文献信息

• 硝基呋喃类抗结核化合物
  申请人：成都师范学院

  公开号：CN108558858A

  公开（公告）日：2018-09-21

  本发明公开了一种硝基呋喃类抗结核化合物，该化合物结构为或或。该化合物具有很高的抗结核活性，可作为抗结核候选药物。
• AZOLE COMPOUND
  申请人：Aoki Satoshi

  公开号：US20110118311A1

  公开（公告）日：2011-05-19

  A compound which is useful as an active ingredient of a pharmaceutical composition for treating neuropathic pain is provided. The present inventors have made extensive studies on compounds having an FAAH inhibitory activity, and as a result, have found that an azole compound substituted with an N-(pyridine-3-yl)oxycarbonyl-piperidin-4-yl group and a phenyl group or a pharmaceutically acceptable salt thereof has an excellent FAAH inhibitory activity, thereby completing the present invention. The compound of the present invention is confirmed to have an excellent FAAH inhibitory activity and an antiallodynic effect in rat models with neuropathic pain, and thus is useful as an agent for preventing and/or an agent for treating neuropathic pain.

  本发明提供了一种化合物，其作为治疗神经病理性疼痛的药物组合物的有效成分。本发明人对具有FAAH抑制活性的化合物进行了广泛的研究，结果发现，一种被N-（吡啶-3-基）氧羰基哌啶-4-基团和苯基或其药学上可接受的盐所取代的唑啉化合物具有优异的FAAH抑制活性，从而完成了本发明。本发明的化合物已被证实在神经病理性疼痛的大鼠模型中具有优异的FAAH抑制活性和抗痛觉过敏效果，因此可用作预防和/或治疗神经病理性疼痛的药物。
• THIAZOLYL PIPERIDINE DERIVATIVES USEFUL AS H3 RECEPTOR MODULATORS
  申请人：F.HOFFMANN-LA ROCHE AG

  公开号：EP1945635B1

  公开（公告）日：2009-05-06
• US8207199B2
  申请人：——

  公开号：US8207199B2

  公开（公告）日：2012-06-26
• [EN] AZOLE COMPOUND<br/>[FR] COMPOSÉ AZOLE
  申请人：ASTELLAS PHARMA INC

  公开号：WO2010007966A1

  公开（公告）日：2010-01-21

  【課題】神経因性疼痛治療用医薬組成物の有効成分として有用な化合物を提供する。 【解決手段】発明者等は、FAAH阻害活性を有する化合物について鋭意検討した結果、N-(ピリジン-3-イル)オキシカルボニル-ピペリジン-4-イル基及びフェニル基で置換されたアゾール化合物又はその製薬学的に許容される塩が優れたFAAH阻害活性を示すことを知見し、本発明を完成させた。 　本発明化合物は、優れたFAAH阻害活性を有し、ラット神経因性疼痛モデルにおいて抗アロディニア効果が確認できたことから、神経因性疼痛の予防剤及び/又は治療剤として有用である。